Amo,
I've been a SH for quite awhile. Love the SphygmoCor-XCEL device and have used it with great feedback for my age. I have suggested to a number of colleagues that they should also take advantage of the service. Alas, you can only lead a horse to water, you can't make it drink the water. However, it has been a hard slog to get the product to generate a meaningful return. No fault of the product. It is always hard to get people (any) to accept change, unless of course it comes from Apple. Medicos like most professions are slow to take on new concepts/products. They fear what they do not understand and/or they are lazy to invest the time to learn something new.
The new board are taking a new approach which will be more aligned to a "total health" solution. I am all for this, given that I spend more on my personal preventative health care than I do servicing my car. I think, unlike most, I have my priorities right.
If you take your personal health seriously then learn as much as possible about what it is the coy is offering. Almost all the GPs I have spoken to have never heard of SphygmoCor-XCEL device.
I am most impressed by the willingness of the CEO to use this medium when mis-informed contributors make incorrect comments. I only know of one other coy that I follow where this approach is taken by a company.
From my point of view, I think the SP will continue to go sideways until there is positive cash-flow or the likelihood of such. I am sure there will be more CR and if the last one is any indication there will be no lack of takers. For me, I am a long-term holder and have a significant holding, for me.
JMT
- Forums
- ASX - By Stock
- Potential for CDX
CDX
cardiex limited
Add to My Watchlist
2.50%
!
3.9¢

Amo,I've been a SH for quite awhile. Love the SphygmoCor-XCEL...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $20.01K | 521.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 0.038 |
5 | 677100 | 0.037 |
2 | 263210 | 0.036 |
4 | 515503 | 0.035 |
3 | 382970 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 60000 | 1 |
0.045 | 82414 | 2 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 15.40pm 27/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online